STOXX Ltd has announced its acquisition of Nice, France-based Scientific Beta, which it describes as ‘known for its world-class research capabilities, and its suite of smart beta, climate, and enhanced cap-weight indices’.
The firm writes that the transaction strengthens STOXX’s position as a leading provider of systematic, research-driven index solutions and advances its strategy to deepen engagement with asset owners, globally.
Originally founded within EDHEC-Risk Institute, Scientific Beta has built a strong reputation for translating academic research into transparent, rules-based equity strategies designed for institutional investors. The firm, founded in 2012 and part of the SGX Group, has approximately 40 full-time employees based primarily in Nice as well as London, Singapore, and Sydney.
The firm writes that the acquisition combines Scientific Beta’s academically grounded factor research and signal design capabilities with STOXX’s index expertise to deliver factor indices. Together, the integrated offering establishes a differentiated, end-to-end investment platform spanning research, signal development, portfolio construction, and benchmark implementation.
“This acquisition will accelerate our strategy to deliver scalable, research-driven, and cost-effective index solutions to institutional investors globally,” says Gary Retelny, President & CEO of ISS STOXX. “It strengthens our ability to meet the growing demand for systematic, rules-based strategies that are undergirded by world-class research, for institutional investors across the globe.”
STOXX writes that the addition of Scientific Beta is expected to accelerate STOXX’s expansion within the asset owner segment and deepen engagement with large institutional investors. Its wide-ranging capabilities further strengthen STOXX’s ability to deliver customized, research-led portfolio solutions and to embed its benchmarks more deeply within institutional mandates.
“The addition of Scientific Beta and its highly talented team underscore our commitment to delivering differentiated indexing solutions, grounded in industry leading research, that enhance our clients’ investment processes,” says Axel Lomholt, STOXX General Manager. “Asset owners are increasingly seeking strategies that combine academic rigor with real-world implementation at scale. Bringing Scientific Beta into STOXX strengthens our ability to meet this demand, offering clients seamless access to advanced factor research, robust portfolio construction, and scalable index implementation within a single, integrated platform.”